Friday 4 November 2016
|09.45-10.00||Welcome and introductions, UK-CAB updates, company pre-meeting|
|10.00-10.30||Personal perspective as a TB patient – Johnson Mwangi|
|10.30-11.15||TB service across England – Lynn Altass , National TB Strategy Programme, NHS England/PHE|
|11.30-12.30||HIV lung health – Dr Stephen Aston, Wellcome Trust|
IAS and R4P – Roger Pebody
BHIVA – Jo Josh and Roy Trevelion
HIV Glasgow -Roy Trevelion
Presentations from this meeting:
Personal perspective as a TB patient
TB services across England
HIV and lung health
– Slide set 1
– Slide set 2
– Slide set 3
– IAS and Research for Prevention
– BHIVA Autumn conference
– HIV Glasgow conference
NHS Choices for TB: An introduction to TB covering, symptoms, causes, diagnosis and treatment
All you need to know about Tuberculosis, explained in six short web clips by MSF:
Would recommend at least watching these two short videos:
- How the body reacts to tuberculosis (3mins)
An estimated one-third of the world’s population is infected with TB. But does that mean 2.3 billion people are sick? Fortunately not, as only a small proportion of them actually become so. To understand why, let’s take a closer look at the bacterium itself.
- Fighting tuberculosis (2.10mins)
The weapons used to fight tuberculosis are now completely outdated: the diagnostic tools are slow, complicated and unreliable. The drugs used are 50 years old and an effective vaccine for children and adults is still a long way off. But despite all this, there’s some good news on the horizon.
UK TB Stats and Targets:
Despite many people believing TB has been eradicated in the UK it never went away. In fact, the UK experienced a two decade long rise in cases from the mid-1980s. It is only in the last four years that the UK has begun to match the global trend for falling rates of TB, with affected individuals dropping from a peak of 8,919 cases in 2011 to around 6,000 cases annually today.
COPD (chronic obstructive pulmonary disease)
What is COPD?
This is a general introduction to COPD covering causes, symptoms, diagnosis, treatment, diet etc.
HIV positive people on ART have impaired alveolar immunity
BHIVA presentation by Professor Paul Collini from University of Sheffield on some interesting immunological results that suggest that macrophages in the lungs of HIV positive people may be impaired, even after viral suppression on ART.
Webcast from BHIVA : http://www.bhiva.org/160421PaulCollini.aspx (12mins)
Article in HTB: http://i-base.info/htb/30036
Smoking cessation (COPD) presentation at BHIVA by Dr Louise Restrick: Helping Smokers Quit Adding value to HIV Care? This webcast is 28 mins.
The UK-CAB receives unrestricted funding from some pharmaceutical companies towards the direct costs of holding four meetings each year. This funding supports the travel and accommodation costs for members to attend from outside London, plus the cost of catering.
The content, programme and agenda for meetings is decided by the UK-CAB steering group in consultation with the wider membership. Funding is unconnected to meeting content.
We believe that manufacturers who currently develop and market medicines have a responsibility to actively engage with advocacy organisations and that HIV positive people and their advocates should be able to directly question manufacturers about the safety and efficacy of their products and proposals for future research.
For a list of companies that support the UK-CAB please see the “about us” page.